BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10828489)

  • 1. New frontiers in the biology of GLP-2.
    Lovshin J; Drucker DJ
    Regul Pept; 2000 Jun; 90(1-3):27-32. PubMed ID: 10828489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological actions and therapeutic potential of the glucagon-like peptides.
    Drucker DJ
    Gastroenterology; 2002 Feb; 122(2):531-44. PubMed ID: 11832466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling.
    Estall JL; Drucker DJ
    J Nutr; 2003 Nov; 133(11):3708-11. PubMed ID: 14608100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide 2 function in domestic animals.
    Burrin DG; Stoll B; Guan X
    Domest Anim Endocrinol; 2003 Mar; 24(2):103-22. PubMed ID: 12586312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide 2.
    Drucker DJ
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1759-64. PubMed ID: 11297614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: the glucagon-like peptides.
    Drucker DJ
    Endocrinology; 2001 Feb; 142(2):521-7. PubMed ID: 11159819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
    Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
    Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
    Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic properties and therapeutic potential of glucagon-like peptide-2.
    Drucker DJ; Boushey RP; Wang F; Hill ME; Brubaker PL; Yusta B
    JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S98-100. PubMed ID: 10483906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.
    Lovshin J; Yusta B; Iliopoulos I; Migirdicyan A; Dableh L; Brubaker PL; Drucker DJ
    Endocrinology; 2000 Nov; 141(11):4194-201. PubMed ID: 11089553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.
    Lee J; Koehler J; Yusta B; Bahrami J; Matthews D; Rafii M; Pencharz PB; Drucker DJ
    Mol Metab; 2017 Mar; 6(3):245-255. PubMed ID: 28271031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut adaptation and the glucagon-like peptides.
    Drucker DJ
    Gut; 2002 Mar; 50(3):428-35. PubMed ID: 11839727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 2: a nutrient-responsive gut growth factor.
    Burrin DG; Petersen Y; Stoll B; Sangild P
    J Nutr; 2001 Mar; 131(3):709-12. PubMed ID: 11238747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.
    Drucker DJ; Yusta B
    Annu Rev Physiol; 2014; 76():561-83. PubMed ID: 24161075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.
    Thulesen J
    Curr Protein Pept Sci; 2004 Feb; 5(1):51-65. PubMed ID: 14965320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.
    Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL
    Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
    Drucker DJ
    Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptides.
    Drucker DJ
    Diabetes; 1998 Feb; 47(2):159-69. PubMed ID: 9519708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.
    Boushey RP; Yusta B; Drucker DJ
    Cancer Res; 2001 Jan; 61(2):687-93. PubMed ID: 11212269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E; Dworzecki T
    Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.